Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes
Endocrine Journal · 2026 · 73 (11) · 1185-1191
DOI: 10.1507/endocrj.ej26-0170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Journal, 2026. Verfasst von Takeshi Yagihashi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Metabolism and Endocrinology, International University of Health and Welfare, Narita Hospital, Chiba 286-8520, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Autoantibodies, Dipeptidyl Peptidase 4. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diabetes, Metabolism and Endocrinology, International University of Health and Welfare, Narita Hospital, Chiba 286-8520, Japan.
- Department of Diabetes, Metabolism and Endocrinology, International University of Health and Welfare, Atami Hospital, Shizuoka 413-0012, Japan.
- Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
- Department of Diabetes, Metabolism and Endocrinology, School of Medicine, International University of Health and Welfare, Chiba 286-8686, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Yagihashi, T., Hashimoto, T., Ohtake, N., Okamoto, T., Zhang, B. S., Yoshida, Y., Yamaga, M., Yoshida, T., Kajiyama, A., Furukawa, R., Hiwasa, T., & Takemoto, M. (2026). Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes. Endocrine Journal, 73(11), 1185-1191. https://doi.org/10.1507/endocrj.ej26-0170
Vancouver
Yagihashi T, Hashimoto T, Ohtake N, Okamoto T, Zhang BS, Yoshida Y, et al. Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes. Endocrine Journal. 2026;73(11):1185-1191. doi:10.1507/endocrj.ej26-0170
BibTeX
@article{Yagihashi2026,
author = {Yagihashi, Takeshi and Hashimoto, Takahide and Ohtake, Naoki and Okamoto, Tokiko and Zhang, Bo-Shi and Yoshida, Yoichi and Yamaga, Masaya and Yoshida, Tomohiko and Kajiyama, Amika and Furukawa, Rikako and Hiwasa, Takaki and Takemoto, Minoru},
title = {Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes},
journal = {Endocrine Journal},
year = {2026},
volume = {73},
number = {11},
pages = {1185--1191},
doi = {10.1507/endocrj.ej26-0170}
}
EUVIMED